Table 1.
Summary data from 117 cancer-bearing cats treated with surgery and an adjuvanted whole-cell autologous cancer vaccine (ACV)
| Variable | |
|---|---|
| Age (years) | 11.1 ± 3.33 |
| Range | 3.0–19.9 |
| Weight (kg) | 5.1 ± 1.70 |
| Range | 1.8–13.4 |
| Sex | |
| Male | 58 (49.6) |
| Female | 59 (50.4) |
| Reproductive status | |
| Neutered | 114 (97.4) |
| Intact | 3 (2.6) |
| Breed | |
| Domestic shorthair | 84 (71.8) |
| Domestic longhair | 13 (11.1) |
| Maine Coon | 4 (3.4) |
| Other breeds | 16 (13.7) |
| Cancer origin | |
| Epithelial | 48 (41.0) |
| Mesenchymal | 59 (50.4) |
| Round cell | 10 (8.5) |
| Doses of Torigen ACV administered | 438 |
| Doses per cat | 3.7 ± 3.29 |
| Range | 1–36 |
| AEs | 7 |
| Affected cats | 6 (5.1) |
| Doses associated with AEs | 6 (1.4) |
| Doses associated with serious AEs | 1 (0.2) |
Data are n (%) or mean ± SD
AEs = adverse events